Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients

Fuster D, Nunes D, Cheng DM, Saitz R, Samet JH. Alcohol Consumption and Hepatitis C Virus (HCV) RNA Levels in HIV/HCV Coinfected Patients. Viruses. 2021; 13(5):716.
Publication Date


Background: The impact of Hepatitis C virus (HCV) RNA levels on the evolution of chronic HCV infection-related liver damage is controversial. Heavy alcohol use is believed to have a deleterious impact on the course of HCV disease, but current knowledge about the possible effect of alcohol use on HCV RNA levels in HIV/HCV coinfected patients is limited.

HepHIV 2021


The next HepHIV conference will take place 5-7 May 2021 involving participants from across the community, public health and the health system. Due to the COVID-19 pandemic, the HepHIV2021 Lisbon Conference will take place via a virtual platform. A Portuguese national meeting will be arranged if feasible

Updated HIV Clinical and Service Delivery Recommendations


In late 2020, WHO developed new clinical and service delivery recommendations on key topic areas outlined in the agenda below. To launch and discuss these recommendations, WHO will host a webinar with a brief question and answer session, open to all participants.

Provisional agenda

Director’s Welcome - Department of Global HIV, Hepatitis and Sexually Transmitted Infection Programmes

EU HCV Elimination Policy Summit


Despite the progress that has been made in recent years, HCV remains a major public health problem in Europe. In the European Union (EU) more people die each year from HCV than from HIV/AIDS. 

Toxins in Marijuana Smoke May Be Harmful to Health, Study Finds

Publication Date

Smoking weed may expose people to the same type of toxic chemicals found in tobacco smoke, a new study finds. People who only smoked marijuana had higher blood and urine levels of several smoke-related toxins such as naphthalene, acrylamide and acrylonitrile than nonsmokers. 

HIV and Methamphetamine Use: Double Jeopardy for Transmission of the Novel Coronavirus.

Publication Date

A cross-country group of researchers funded by NIDA has identified needed areas of research related to the intertwining epidemics of HIV, COVID-19 and the increasing use of methamphetamine in the United States among men who have sex with men. The authors suggest that co-occurring methamphetamine use and HIV present compounded risk for contracting the novel coronavirus (SARS-CoV-2), helping to fuel the current COVID-19 pandemic.

HIV Research for Prevention Conference


Registration to the 4th HIV Research for Prevention Conference (HIVR4P // Virtual) is now open! Take part and access the latest in biomedical HIV prevention research and implementation in a new virtual format and accessible from around the world.

HIVR4P // Virtual will include the world’s leading HIV prevention researchers, implementers and advocates, along with the latest science in 29 research categories.

Toolkit for Opioids, Alcohol & Tobacco in HIV

Created by
Yale University

The Yale Program in Addiction is pleased to make available resources from the Working with HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (WHAT-IF?) multi-site study, for any HIV or primary care clinic seeking to integrate addiction treatments for Tobacco, Alcohol, Opioid, and other substance use disorders into their clinical practice and care models.